Follow
Fernando Vieira
Fernando Vieira
CEO and Chief Scientific Officer, ALS Therapy Development Institute
Verified email at als.net
Title
Cited by
Cited by
Year
Design, power, and interpretation of studies in the standard murine model of ALS
S Scott, JE Kranz, J Cole, JM Lincecum, K Thompson, N Kelly, A Bostrom, ...
Amyotrophic Lateral Sclerosis 9 (1), 4-15, 2008
5122008
Guidelines for preclinical animal research in ALS/MND: A consensus meeting
AC Ludolph, C Bendotti, E Blaugrund, A Chio, L Greensmith, JP Loeffler, ...
Amyotrophic Lateral Sclerosis 11 (1-2), 38-45, 2010
2962010
From transcriptome analysis to therapeutic anti-CD40L treatment in the SOD1 model of amyotrophic lateral sclerosis
JM Lincecum, FG Vieira, MZ Wang, K Thompson, GS De Zutter, J Kidd, ...
Nature genetics 42 (5), 392-399, 2010
1222010
No benefit from chronic lithium dosing in a sibling-matched, gender balanced, investigator-blinded trial using a standard mouse model of familial ALS
A Gill, J Kidd, F Vieira, K Thompson, S Perrin
PLoS One 4 (8), e6489, 2009
982009
C57BL/6J congenic Prp-TDP43A315T mice develop progressive neurodegeneration in the myenteric plexus of the colon without exhibiting key features of ALS
T Hatzipetros, LP Bogdanik, VR Tassinari, JD Kidd, AJ Moreno, C Davis, ...
Brain research 1584, 59-72, 2014
952014
Guanabenz treatment accelerates disease in a mutant SOD1 mouse model of ALS
FG Vieira, Q Ping, AJ Moreno, JD Kidd, K Thompson, B Jiang, ...
PloS one 10 (8), e0135570, 2015
702015
A quick phenotypic neurological scoring system for evaluating disease progression in the SOD1-G93A mouse model of ALS
T Hatzipetros, JD Kidd, AJ Moreno, K Thompson, A Gill, FG Vieira
JoVE (Journal of Visualized Experiments), e53257, 2015
662015
Personalizing ASR for dysarthric and accented speech with limited data
J Shor, D Emanuel, O Lang, O Tuval, M Brenner, J Cattiau, F Vieira, ...
arXiv preprint arXiv:1907.13511, 2019
622019
Degeneration of proprioceptive sensory nerve endings in mice harboring amyotrophic lateral sclerosis–causing mutations
SK Vaughan, Z Kemp, T Hatzipetros, F Vieira, G Valdez
Journal of Comparative Neurology 523 (17), 2477-2494, 2015
602015
SOD1-positive aggregate accumulation in the CNS predicts slower disease progression and increased longevity in a mutant SOD1 mouse model of ALS
C Gill, JP Phelan, T Hatzipetros, JD Kidd, VR Tassinari, B Levine, ...
Scientific reports 9 (1), 1-13, 2019
552019
A human-derived antibody targets misfolded SOD1 and ameliorates motor symptoms in mouse models of amyotrophic lateral sclerosis
M Maier, T Welt, F Wirth, F Montrasio, D Preisig, J McAfoose, FG Vieira, ...
Science translational medicine 10 (470), eaah3924, 2018
502018
Proteomic analysis reveals differentially regulated protein acetylation in human amyotrophic lateral sclerosis spinal cord
D Liu, C Liu, J Li, K Azadzoi, Y Yang, Z Fei, K Dou, NW Kowall, HP Choi, ...
PLoS One 8 (12), e80779, 2013
362013
Phase IIa trial of fingolimod for amyotrophic lateral sclerosis demonstrates acceptable acute safety and tolerability
JD Berry, S Paganoni, N Atassi, EA Macklin, N Goyal, M Rivner, ...
Muscle & nerve 56 (6), 1077-1084, 2017
352017
CuATSM efficacy is independently replicated in a SOD1 mouse model of ALS while unmetallated ATSM therapy fails to reveal benefits
FG Vieira, T Hatzipetros, K Thompson, AJ Moreno, JD Kidd, VR Tassinari, ...
IBRO reports 2, 47-53, 2017
322017
Dexpramipexole is ineffective in two models of ALS related neurodegeneration
FG Vieira, E LaDow, A Moreno, JD Kidd, B Levine, K Thompson, A Gill, ...
PLoS One 9 (12), e91608, 2014
232014
The ALS-inducing factors, TDP43A315T and SOD1G93A, directly affect and sensitize sensory neurons to stress
SK Vaughan, NM Sutherland, S Zhang, T Hatzipetros, F Vieira, G Valdez
Scientific reports 8 (1), 1-12, 2018
162018
Method for the treatment of neurodegenerative diseases
S Perrin, JM Lincecum, A Gill, F Vieira
US Patent 8,435,514, 2013
142013
Design, power, and interpretation of studies in the standard murine model of ALS. Amyotroph Lateral Scler. 2008; 9: 4–15
S Scott, JE Kranz, J Cole, JM Lincecum, K Thompson, N Kelly, A Bostrom, ...
14
Impact of IL-1β on flow-induced outward arterial remodeling
Z Jiang, SA Berceli, CL Pfahnl, L Wu, CD Killingsworth, FG Vieira, ...
Surgery 136 (2), 478-482, 2004
92004
Primary neurons and differentiated NSC-34 cells are more susceptible to arginine-rich ALS dipeptide repeat protein-associated toxicity than non-differentiated NSC-34 and CHO cells
AL Gill, MZ Wang, B Levine, A Premasiri, FG Vieira
International journal of molecular sciences 20 (24), 6238, 2019
72019
The system can't perform the operation now. Try again later.
Articles 1–20